Ivlv-ADA

· Shenzhen Geno-Immune Medical Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ivlv-ADA, covering 2025-09-09 to 2025-09-09. Get the full timeline:

Most recent: Clinical Trial Update: Gene Therapy for ADA-SCID Using an Improved Lentiviral Vector (Ivlv-ADA) [NA]